In re Medical Components, Inc.
U.S. District Court for the District of Utah
Holding
The Federal Circuit denied mandamus. MedComp did not show a clear and indisputable right to relief based on an alleged conflict between the Utah court's post-remand ruling and the mandate in a different AngioDynamics appeal.
Why It Matters
The order underscores that mandamus is unlikely to police alleged mandate errors where the asserted mandate came from a separate proceeding rather than the same case.
Full Summary
Key Points
- Bard accuses MedComp of infringing patents directed to systems and methods for identifying whether a venous access port is power injectable.
- After an earlier Federal Circuit remand following reversal of a § 101 ruling, MedComp sought summary judgment that the asserted claims were anticipated by the Jones patent.
- The district court denied summary judgment, construing disputed limitations such as “power injectable/suitable for power injection” as reflecting the port's functionality rather than mere printed matter, and finding Jones did not disclose a power-injectable port.
- MedComp sought mandamus, arguing the district court was required to give no patentable weight to the disputed limitations under AngioDynamics II.
- The Federal Circuit denied relief because the alleged mandate constraint arose from a different case, not the same proceeding, and MedComp did not satisfy the demanding mandamus standard.
- Patent eligibility (§ 101) →
- Anticipation and prior art (§ 102) →
- Claim construction →
- Federal Circuit patent decisions →
- Fed. Cir. · Sept. 30, 2026EPIC TECH, LLC v. PEN-TECH ASSOCIATES, INC.
- Fed. Cir. · Sept. 25, 2026Receivership Estate of AudienceScience Inc. v. Google LLC
- Fed. Cir. · Sept. 21, 2026BERKELEY*IEOR v. W.W. Grainger Inc.
- Fed. Cir. · Aug. 31, 2026Constellation Designs, LLC v. LG Electronics Inc.
- Fed. Cir. · Aug. 28, 2026AML IP, LLC v. Bath & Body Works Direct, Inc.